06/17/2026
For a patient waiting on treatment, prior authorization is rarely just paperwork. It’s the days or weeks between a doctor’s decision and the care that decision was supposed to deliver—time a serious illness doesn’t always give back.
That’s why we submitted a public comment on the 2026 CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule (CMS-0062-P) —the federal government’s most significant attempt yet to fix how prior authorization works for medications.
Take a look at what we had to say right here:
In its 2026 comment to CMS, Patients Rising urged faster prior authorization decisions, plain-language denials, and an end to timing-based lab-test denials.